UroGen Pharma Ltd. ( URGN) - Key Metrics
URGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.44 | -$0.28 | -$0.66 | -$0.66 |
| 2026Q1 | $1.02 | -$0.47 | -$0.90 | -$0.90 |
| 2025Q4 | $0.77 | -$0.54 | -$0.78 | -$0.78 |
| 2025Q3 | $0.57 | -$0.69 | -$0.88 | -$0.88 |
| 2025Q2 | $0.51 | -$1.05 | -$0.83 | -$0.84 |
URGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -32.86 |
| 2026Q1 | 0% | -9.56 |
| 2025Q4 | 0% | -10.84 |
| 2025Q3 | 0% | -7.23 |
| 2025Q2 | 0% | -3.26 |
URGN
Price: $36.61
52 week price:
Earnings Per Share: -1.97 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20983
Ebitda: -286000Market Capitalization: 2.0 billion